Recent advances in molecular genetics have led to the cloning of human genes for granulocyte-macrophage colony-stimulating factor (GM-CSF) (1) (2) (3) , granulocyte colony-stimulating factor (G-CSF) (4, 5) , and macrophage-specific colonystimulating factor (CSF-1) (6) . Transfection of these genes into monkey COS cells results in the production of proteins having growth factor activity. G-CSF and CSF-1 promote growth of granulocyte and macrophage colonies, respectively, when tested in appropriate culture systems (4) (5) (6) . In contrast, GM-CSF displays stimulatory activities for multiple precursors. These include progenitors committed to granulocyte and macrophage production (1) (2) (3) (7) (8) (9) , erythropoiesis (3, (7) (8) (9) , and megakaryocytopoiesis (3) , as well as pluripotent precursors (7) (8) (9) . However, the frequency of erythroid bursts and of megakaryocyte and multilineage colonies was consistently lower than that observed in cultures stimulated by crude conditioned media as a source of multiple growth factors (3, 9) . This observation raises the question whether or not GM-CSF is the only multipotent human CSF or whether other molecules equivalent to murine interleukin 3 (IL-3) exist.
Recently, cDNA sequences were isolated in a gibbon T-cell line that demonstrated homology to the gene encoding murine IL-3 (10) . Supernatants of COS-1 cells transfected with this gene promote activity for the growth of erythroid and nonerythroid colonies. By using the same probe, homology was observed with human cDNA sequences for IL-3.
In a series of experiments, we have tested IL-3-containing COS-1 cell supernatants on human bone marrow cells and compared their stimulatory effect for various hemopoietic precursors to that of medium conditioned by phytohemagglutinin-stimulated leukocytes (PHA-LCM) and to those of recombinant GM-CSF and G-CSF.
MATERIALS AND METHODS
Patient Material. Bone marrow cells were obtained from consenting normal volunteers. T-lymphocyte-depleted, nonadherent, mononuclear target cell suspensions were prepared as described previously (11, 12) .
Sources of Recombinant Growth Factors. Recombinant human GM-CSF and G-CSF as well as gibbon IL-3 were obtained as supernatants from Chinese hamster ovary cells (GM-CSF) or COS-1 cells (G-CSF, IL-3) transfected with the respective genes (Genetics Institute, Cambridge, MA). The supernatants contained 0.5-1.0 Ag of protein per ml. They were serially diluted and used at concentrations ranging from 1:102 to 1:105.
Recombinant erythropoietin (Epo) was purchased from Amgen Biologicals (Thousand Oaks, CA) (13).
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Colonies of the granulocyte-macrophage series appeared to grow at optimal frequency when higher concentrations of IL-3 were used. In particular, eosinophil colonies were predominant in cultures containing the highest concentration of IL-3 tested (1:102 dilution). At high IL-3 concentration, basophil colonies could be recognized at low frequency (17, 18) .
Colony formation promoted by the gibbon recombinant IL-3 was compared in four experiments to that of human recombinant GM-CSF and G-CSF (Fig. 1) . The data are expressed as percentage of the PHA-LCM control.
GM-CSF at a dilution of 1:103 yielded multilineage colonies in three experiments and erythroid bursts as well as megakaryocyte colonies in all four studies. The frequency was significantly lower when compared to IL-3 used at a dilution of 1:103. The formation of neutrophil, eosinophil, and granulocyte-macrophage colonies was equivalent to or better than that of PHA-LCM controls. Macrophage colony formation varied widely in these three experiments.
G-CSF stimulated the formation of neutrophil and a small number of eosinophil colonies without promoting growth of granulocyte-macrophage colonies, erythroid bursts, and megakaryocyte and multilineage colonies. Mixing experiments were performed to study the effect on colony formation when IL-3 was added to cultures simultaneously with GM-CSF or G-CSF. Based on previous experiments, IL-3 was used at dilutions of 1:105, 1:104, and 1:103. GM-and G-CSF were added at dilutions covering the same range. Each culture was assessed for the presence of seven different colony types.
The plating efficiency of CFU-GEMM was optimal and comparable to that of PHA-LCM controls in plates containing IL-3 at a dilution of 1:103. The frequency of multilineage colonies was not increased by further addition of GM-CSF (Fig. 2A) or G-CSF (data not shown). In contrast, when IL-3 was used at suboptimal concentrations (dilutions of 1: 104 and 1:105), addition of GM-CSF resulted in a dose-dependent increase in multilineage colonies (Fig. 2A) . However, the frequency of these colonies remained lower in comparison to results obtained at the optimal concentration of IL-3. The effect of IL-3 and GM-CSF was not additive. The frequency of multilineage colonies in cultures grown with various concentrations of GM-CSF increased and reached PHA-LCM control values when IL-3 was added at 1:103 (Fig. 2B) .
As shown in Fig. 2 C-F, BFU-E and CFU-Meg behaved similarly. The frequency of erythroid bursts and megakaryocyte colonies in cultures plated with IL-3 at a dilution of 1:105 improved with GM-CSF but did not approximate that of PHA-LCM controls.
The response pattern ofclonogenic precursors belonging to the granulocyte-macrophage series was different (Fig. 3) . Optimal colony formation by CFU-G, CFU-Eo, CFU-GM, and CFU-M was achieved with GM-CSF. Addition of IL-3 at higher concentrations appeared to augment colony formation by CFU-Eo beyond values observed with optimal concentrations ofGM-CSF. The frequency ofthe other granulocytemacrophage progenitors was increased by addition of IL-3 only when GM-CSF was present at suboptimal concentrations.
G-CSF gave maximal growth support of CFU-G without affecting CFU-Eo, CFU-GM, and CFU-M (Fig. 4) .
Comparison of the Growth-Promoting Effects of Human Plasma and Fetal Calf Serum in Cultures Containing Recombinant IL-3. Human plasma supports the growth of hemopoietic colonies in general, and megakaryocyte colonies in particular, more effectively than fetal calf serum (11) . We have compared the effect of IL-3 with that of PHA-LCM using human plasma and fetal calf serum in three experiments. Human plasma promoted the formation of every colony type more efficiently than fetal calf serum independent of whether PHA-LCM or IL-3 was used, as shown by a representative experiment (Table 2 ). In particular, the frequency of megakaryocyte colonies was substantially higher with human plasma than with fetal calf serum. (21) .
IL-3 was more effective than GM-CSF in promoting growth of CFU-GEMM, BFU-E, and CFU-Meg. Further addition of GM-CSF to cultures containing IL-3 at optimal concentration did not increase the frequency of multilineage colonies, erythroid bursts, or megakaryocyte colonies. The plating efficiency of all three types of precursors improved with GM-CSF when IL-3 was present at suboptimal concentrations. The maximal effect, however, was less than additive. This observation is consistent with the view that GM-CSF may promote growth of a subpopulation of IL-3-responsive CFU-GEMM, BFU-E, and CFU-Meg.
In contrast, GM-CSF promotes optimal growth of granulocyte-macrophage precursors while IL-3 stimulates only a subpopulation of GM-CSF-sensitive cells.
As previously found for PHA-LCM-stimulated cultures, colony formation by all hemopoietic progenitors but especially by megakaryocyte precursors is enhanced with human plasma as compared to fetal calf serum (11) . This observation was reproduced when IL-3 was used instead of PHA-LCM. It is not known whether plasma provides only some essential nutrients or whether it may also serve as a source of as-yet-unidentified growth factors. The development of a plasma-and serum-free culture system for hemopoietic progenitors may help to answer this question.
IL-3 may interact with clonogenic target cells directly rather than through signals produced by auxiliary cells as convincingly shown in cultures of single mechanically separated murine pluripotent precursors (22) . This view is supported by our observation that target cells extensively depleted of auxiliary cell populations were able to form colonies in response to recombinant IL-3.
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